Putting the Patient First in IBD Care: Risk Assessment and Treatment
Program Overview
The goal of this activity is to provide education about tools for assessing the risk of disease complications in patients with IBD and how to personalize treatment based on patient goals and individual disease considerations.
This activity is intended for gastroenterology and primary care physicians, nurse practitioners, and physician assistants who manage patients with inflammatory bowel disease (IBD).
Educational Objectives
Upon completion of this activity, participants should be better able to:
Discuss the importance of and methods by which to perform early risk stratification for patients with IBD
Apply evidence-based IBD management strategies based on risk of disease complications
Implement individualized IBD treatment approaches based on expected benefits and risks
Activity Faculty
Corey A. Siegel, MD, MS
Professor of Medicine and of The Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine at Dartmouth Section Chief, Gastroenterology and Hepatology Co-Director, IBD Center
Dartmouth-Hitchcock Medical Center
Lebanon, NH
Marla C. Dubinsky, MD
Professor, Pediatrics and Medicine Chief, Pediatric Gastroenterology and Nutrition Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine
Kravis Children’s Hospital Mount Sinai
New York, NY
Iris Dotan, MD
Director, Division of Gastroenterology
Rabin Medical Center
Petah Tikva, Israel Sackler Faculty of Medicine
Tel Aviv University
Tel Aviv, Israel